@tylerblack32 also, as I'm sure you know, potency and "fast dissociation" are related but distinct issues. we dose according to potency, but much of EPS risk is related to relative anticholinergic activity at that dose (e.g. CPZ). and LOX isn't QTP-like.
@markbgger @CarlatPsych @DrEdwardShorter Thank you I'll bring that to our editorial board. Some think it is similar to clozapine and has atypical properties: https://t.co/8XKfiRD3nU
#Loxapina Inhalada: Rev Sistem 2015 http://t.co/zx5FOshACz Antipsicotico #vintage con administración innovadora en agitación x Esquiz-TB
Loxapina Inhalada:Rev 2015 http://t.co/wD8khgRS8R Antipsicotico #vintage con administración innovadora en agitación x Esquiz-TB @MRGUEZGLEZ